Caitlin Owens is a Health Care Reporter at Axios. She specializes in themes such as health and wellness, healthcare systems, pharmaceuticals, and public health, often covering topics like consumer health, drugs and medication, and healthcare administration. Caitlin's work has been featured in notable outlets including Yahoo News, Flipboard, and Editor & Publisher Magazine.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Caitlin Owens focuses on national healthcare policy, particularly around government announcements, legal and regulatory developments. She frequently cites data and delves into topics such as healthcare inequality, the addiction crisis, mental health, aging population and health insurance.
To effectively pitch to Caitlin Owens, consider offering insights or expert commentary related to US national healthcare policy changes or proposals. If you have access to relevant data or can provide analysis of government announcements regarding healthcare policies in the United States, this could be of interest.
Given her focus on politics and frequent coverage of government announcements within the realm of healthcare policy regulation in the US, she may appreciate pitches that offer insightful analysis or exclusive information pertaining to ongoing legislative efforts surrounding these issues.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Controversial vaccine policy changes appear to be roaring back ahead of the midterms.
President Trump issued an executive order Monday calling for fewer childhood vaccinations, splitting the childhood MMR vaccine into three shots and delivering vaccines at separate medical visits.
President Trump issued an executive order Monday calling for fewer childhood vaccinations, splitting the childhood MMR vaccine into three shots and delivering vaccines at separate medical visits.
The new order suggests Trump isn't through with ordering significant changes after being stalled by courts.
What's the common thread connecting AI advances, biological breakthroughs, a preponderance of high-risk-high-reward research, escalating geopolitical tensions and a hollowed-out U.S. public health sector?
The Food and Drug Administration is considering evaluating generative AI-enabled medical devices through a "competency-based approach," similar to
President Trump has decided to nominate White House aide Heidi Overton to lead the Food and Drug Administration, according to a senior administration official.
The American Medical Association is out with a new framework for physicians' role in the age of AI, provided first to Axios, that insists doctors remain central to patient care.
President Trump announced Wednesday he's nominating White House aide Heidi Overton to lead the Food and Drug Administration.
The debate over AI and public safety isn't one that the health care or research communities can ignore.
